Your compass for disease incidence and prevalence
Confidently navigate the ebb and flow of infectious diseases in your community – and beyond – with QIAsphere Insights. With data from your own QIAstat-Dx instruments and de-identified data from instruments around the world, track everything from pathogen diversity, to rates of co-detection, to Ct value measures. With QIAsphere Insights, the power of clinical epidemiology is in your hands.
Could you be underdiagnosing respiratory infections?
If you're solely relying on low-plex testing, our data suggests you could be missing crucial information. Download our recent study to learn more.
What does QIAsphere Insights offer?
How can QIAsphere Insights support my work?
Useful findings from the Insights dashboard
Low-plex doesn’t cut it for respiratory infections
Our Insights dashboard shows that if you only test your patients for a few viral respiratory pathogens (Influenza A, Influenza B, RSV and SARS-CoV-2), you could be missing a huge proportion of positive cases.
A tale of two (types of) pathogens
The Centers for Disease Control and Prevention estimates that up to 50% of all outpatient antibiotic use may be unnecessary or inappropriate in selection, dose and duration (https://www.cdc.gov/antibiotic-use/data/outpatient-prescribing/index.html).
This rings true with results from our Insights dashboard for respiratory infections. In 2022, bacteria accounted for a very small percentage of positive detections, with viruses making up the vast majority.